Cancer Mutational Load: The More the Merrier for Immune Checkpoint Blockade Therapies.

Cancer Mutational Load: The More the Merrier for Immune Checkpoint Blockade Therapies. — EBioMedicine 20170220

النشر

EBioMedicine 20170220

الوصف

1-2 p.

الموضوعات

Antineoplastic Agents؛ B7-H1 Antigen؛ CTLA-4 Antigen؛ Humans؛ Immunomodulation؛ Molecular Targeted Therapy؛ Mutation؛ Neoplasms